A native of Belgium, Dr. Urbain earned his Medical Degree at the University of Louvain, Belgium, and then pursued residency training in Internal Medicine and Nuclear Medicine at the University Hospital of the University of Louvain in Brussels, Belgium. He subsequently obtained a Ph.D. in Genetics and Molecular Biology at Temple University in Philadelphia.
Professor of Imaging, Medicine and Biology for more than two decades, Urbain has held leadership and executive positions in Medical Imaging and Medicine in Belgium at the University of Leuven, in Canada at the University of Western Ontario and in the US at Temple University, Fox Chase Cancer Center, The Cleveland Clinic, the VA Administration and now Wake Forest University/Baptist Medical Center. During his career he had the opportunity and privilege to visit hospitals and medical centers and give lecture on all continents.
Urbain has extensive experience and expertise in committees and boards leadership, in the management of integrated health care systems and patient advocacy groups and at regional, national and international levels of government. He has also served as consultant and advisor for Pharmaceutical, Radiopharmaceutical and Medical Systems companies. He worked closely with national and international medical associations and government health authorities to mitigate the major health and medical isotopes crises of 2007-2008, analyzed and helped establish medical resources needs, benchmarks and allocation for key medical service areas.
Urbain was appointed as Secretary of the Belgian Society of Nuclear Medicine in the early 90s’, President of the Canadian Association of Nuclear Medicine (CANM 2006-2011) and President of the Easter Great Lakes Chapter of the SNMMI (2010-2012). Starting on January 1st, 2021 he will assume the Presidency of the World Federation of Nuclear Medicine and Biology.
His current interests are in Precision Medicine and Theranostics, Graduate and Postgraduate Physicians Education, Patients’ Education and Advocacy.